We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-11.26%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$10.3B
AUM Growth
+$1.07B
Cap. Flow
+$2.36B
Cap. Flow %
22.99%
Top 10 Hldgs %
47.42%
Holding
1,109
New
276
Increased
252
Reduced
500
Closed
79

Top Buys

Rank Stock Value
1
WES icon
Western Midstream Partners
WES
+$619M
2
CCJ icon
Cameco
CCJ
+$146M
3
HESM icon
Hess Midstream
HESM
+$80.6M
4
VZ icon
Verizon
VZ
+$58.6M
5
MSFT icon
Microsoft
MSFT
+$51.2M

Sector Composition

Rank Sector Weight
1 Energy 60.43%
2 Technology 6.16%
3 Healthcare 4.82%
4 Consumer Discretionary 4.16%
5 Industrials 3.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIDD icon
1076
Middleby
MIDD
$6.05B
-1,262
Closed -$207K
NGL icon
1077
NGL Energy Partners
NGL
$1.94B
-73,724
Closed -$164K
PDSB icon
1078
PDS Biotechnology
PDSB
$38.1M
-29,221
Closed -$181K
PGRE
1079
DELISTED
Paramount Group
PGRE
-65,861
Closed -$719K
PRAX icon
1080
Praxis Precision Medicines
PRAX
$9.07B
-3,116
Closed -$477K
PRQR icon
1081
ProQR Therapeutics
PRQR
$243M
-73,790
Closed -$67K
SA
1082
Seabridge Gold
SA
$2.8B
-259,722
Closed -$4.8M
SABS icon
1083
SAB Biotherapeutics
SABS
$268M
-4,508
Closed -$170K
SPSC icon
1084
SPS Commerce
SPSC
$2.25B
-2,030
Closed -$266K
SRRK icon
1085
Scholar Rock
SRRK
$5.71B
-36,278
Closed -$468K
SYRE icon
1086
Spyre Therapeutics
SYRE
$8.87B
-2,029
Closed -$117K
TNXP icon
1087
Tonix Pharmaceuticals
TNXP
$157M
-1
Closed -$117K
TRMK icon
1088
Trustmark
TRMK
$2.73B
-26,500
Closed -$805K
TSM icon
1089
TSMC
TSM
$2.09T
-4,226
Closed -$441K
TYL icon
1090
Tyler Technologies
TYL
$12.2B
-470
Closed -$209K
UBER icon
1091
Uber
UBER
$134B
-6,984
Closed -$249K
VALN
1092
Valneva
VALN
$488M
-53,901
Closed -$1.83M
VKTX icon
1093
Viking Therapeutics
VKTX
$4.04B
-80,540
Closed -$242K
VTGN icon
1094
VistaGen Therapeutics
VTGN
$9.29M
-7,075
Closed -$263K
GRTS
1095
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
-74,723
Closed -$308K
WRK
1096
DELISTED
WestRock Company
WRK
-13,138
Closed -$618K
EFTR
1097
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
-1,861
Closed -$187K
ALPN
1098
DELISTED
Alpine Immune Sciences Inc
ALPN
-30,030
Closed -$269K
AMTI
1099
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
-39,730
Closed -$299K
IMPL
1100
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
-23,675
Closed -$151K

Similar funds

ALPS Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, ALPS Advisors held 1,109 positions worth $10.3B, up 12% from $9.22B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

ALPS Advisors deployed $2.36B of net new capital in Q2 2022, opening 276 new positions and adding to 252 existing holdings. Its largest new stake was Western Midstream Partners: 24,175,389 shares worth $588M.

By sector, the portfolio is most concentrated in Energy at 60% of assets, down from 66% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Energy Transfer Partners, an estimated $71M trimmed.

  • ALPS Advisors's largest Q2 2022 buy was Western Midstream Partners: 24,175,389 shares worth $588M.
  • ALPS Advisors added most to Hess Midstream in Q2 2022, an estimated $80.6M increase.
  • ALPS Advisors's biggest Q2 2022 reduction was Energy Transfer Partners, cutting an estimated $71M.
  • ALPS Advisors fully exited People's United Financial Inc in Q2 2022, selling an estimated $23.8M.
  • ALPS Advisors's ten largest holdings make up 47% of its $10.3B portfolio in Q2 2022.
  • ALPS Advisors opened 276 new positions and closed 79 in Q2 2022.
  • ALPS Advisors's portfolio value rose 12% quarter-over-quarter to $10.3B.

Based on ALPS Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.